Definitive Healthcare (DH) Set to Announce Quarterly Earnings on Tuesday

Definitive Healthcare (NASDAQ:DH) is scheduled to be releasing its earnings data after the market closes on Tuesday, May 7th. Analysts expect Definitive Healthcare to post earnings of $0.08 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The firm had revenue of $65.93 million for the quarter, compared to analysts’ expectations of $66.01 million. On average, analysts expect Definitive Healthcare to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Definitive Healthcare Stock Performance

Shares of NASDAQ DH opened at $7.03 on Friday. The company’s fifty day moving average price is $7.85 and its 200 day moving average price is $8.30. Definitive Healthcare has a 1 year low of $5.53 and a 1 year high of $12.45. The company has a market capitalization of $828.06 million, a PE ratio of -3.95, a price-to-earnings-growth ratio of 6.09 and a beta of 1.41. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on DH shares. Stifel Nicolaus lowered their price target on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Wednesday, January 17th. Needham & Company LLC downgraded shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, January 17th. Canaccord Genuity Group increased their price target on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a report on Thursday, February 29th. Finally, Barclays increased their price objective on shares of Definitive Healthcare from $10.00 to $11.00 and gave the company an “equal weight” rating in a report on Friday, March 1st. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $11.31.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.